Recruiting
Phase 2

Pimavanserin

Sponsor:

New York State Psychiatric Institute

Code:

NCT05999240

Conditions

Autism Spectrum Disorder

Eligibility Criteria

Sex: All

Age: 16 - 40

Healthy Volunteers: Not accepted

Interventions

Pimavanserin Tartrate 34 Mg ORAL CAPSULE [NUPLAZID]

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by New York State Psychiatric Institute on 2025-03-25.